Alkali treatment stabilizes fluctuations of urine AQP2 values measured by ELISA

被引：0
|
作者：
Sei Sasaki
Yoko Saijo
Yasukazu Ohmoto
Fusako Iwata
Daisuke Koga
Kiyonori Katsuragi
机构：
[1] Tokyo Medical and Dental University,Department of Nephrology
[2] Otsuka Pharmaceutical Co.,Diagnostic Division, Department of Research and Development
[3] Ltd,Institute of Biomedical Innovation
[4] Otsuka Pharmaceutical Co.,undefined
[5] Ltd,undefined
来源：
Clinical and Experimental Nephrology | 2016年 / 20卷
关键词：
Aquaporin-2; Exosome; Membrane protein; Water balance; Biomarker; Kidney;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：450 / 455
页数：5
相关论文
共 9 条
  • [1] Alkali treatment stabilizes fluctuations of urine AQP2 values measured by ELISA
    Sasaki, Sei
    Saijo, Yoko
    Ohmoto, Yasukazu
    Iwata, Fusako
    Koga, Daisuke
    Katsuragi, Kiyonori
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2016, 20 (03) : 450 - 455
  • [2] Disruption of Membranes of Extracellular Vesicles Is Necessary for ELISA Determination of Urine AQP2: Proof of Disruption and Epitopes of AQP2 Antibodies
    Nameta, Masaaki
    Saijo, Yoko
    Ohmoto, Yasukazu
    Katsuragi, Kiyonori
    Yamamoto, Keiko
    Yamamoto, Tadashi
    Ishibashi, Kenichi
    Sasaki, Sei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (10):
  • [3] AQP2 in human urine is predominantly localized to exosomes with preserved water channel activities
    Yuko Miyazawa
    Saki Mikami
    Keiko Yamamoto
    Masaki Sakai
    Tatsuya Saito
    Tadashi Yamamoto
    Kenichi Ishibashi
    Sei Sasaki
    Clinical and Experimental Nephrology, 2018, 22 : 782 - 788
  • [4] AQP2 in human urine is predominantly localized to exosomes with preserved water channel activities
    Miyazawa, Yuko
    Mikami, Saki
    Yamamoto, Keiko
    Sakai, Masaki
    Saito, Tatsuya
    Yamamoto, Tadashi
    Ishibashi, Kenichi
    Sasaki, Sei
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (04) : 782 - 788
  • [5] Daily variance of urinary excretion of AQP2 determined by sandwich ELISA method
    Sasaki, Sei
    Ohmoto, Yasukazu
    Mori, Toyoki
    Iwata, Fusako
    Muraguchi, Masahiro
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2012, 16 (03) : 406 - 410
  • [6] Treatment with the vascular disrupting agent combretastatin is associated with impaired AQP2 trafficking and increased urine output
    Bohn, Anja B.
    Norregaard, Rikke
    Stodkilde, Lene
    Wang, Yan
    Bertelsen, Lotte B.
    Fenton, Robert A.
    Matchkov, Vladimir V.
    Bouzinova, Elena V.
    Horsman, Michael R.
    Frokiaer, Jorgen
    Stodkilde-Jorgensen, Hans
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2012, 303 (02) : R186 - R198
  • [7] Localization and regulation of PKA-phosphorylated AQP2 in response ito V2-receptor agonist/antagonist treatment
    Christensen, BM
    Zelenina, M
    Aperia, A
    Nielsen, S
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 278 (01) : F29 - F42
  • [8] Differential regulation of autophagy on urine-concentrating capability through modulating the renal AQP2 expression and renin-angiotensin system in mice
    Xu, Chuanming
    Yi, Xiaoli
    Tang, Le
    Wang, Hui
    Chu, Shuhan
    Yu, Jun
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2023, 325 (04) : F503 - F518
  • [9] Long-term aldosterone treatment induces decreased apical but increased basolateral expression of AQP2 in CCD of rat kidney
    de Seigneux, Sophie
    Nielsen, Jakob
    Olesen, Emma T. B.
    Dimke, Henrik
    Kwon, Tae-Hwan
    Frokiaer, Jorgen
    Nielsen, Soren
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2007, 293 (01) : F87 - F99
1